Oral alkalinizing supplementation suppressed intrarenal reactive oxidative stress in mild-stage chronic kidney disease: a randomized cohort study.
Abe M, Yamaguchi T, Koshiba S, Takayama S, Nakai T, Nishioka K, Yamasaki S, Kawaguchi K, Umeyama M, Masaura A, Ishizawa K, Arita R, Kanno T, Akaishi T, Miyazaki M, Abe T, Tanaka T, Ishii T; CKOALA study group.
Abe M, et al. Among authors: abe t.
Clin Exp Nephrol. 2024 Nov;28(11):1134-1154. doi: 10.1007/s10157-024-02517-3. Epub 2024 Jun 13.
Clin Exp Nephrol. 2024.
PMID: 38872014
Free PMC article.
Clinical Trial.